ANI Pharmaceuticals
ANIP
#4988
Rank
HK$12.99 B
Marketcap
HK$578.71
Share price
-0.60%
Change (1 day)
15.74%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : HK$4.86 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is HK$4.86 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$4.84 B117.16%
2023-12-31HK$2.23 B-0.34%
2022-12-31HK$2.23 B-0.1%
2021-12-31HK$2.24 B55.67%
2020-12-31HK$1.43 B-0.49%
2019-12-31HK$1.44 B0.94%
2018-12-31HK$1.43 B-8.97%
2017-12-31HK$1.57 B68.29%
2016-12-31HK$0.93 B6.41%
2015-12-31HK$0.87 B6.39%
2014-12-31HK$0.82 B
2013-12-31N/A-100%
2012-12-31HK$61.1 M-54.62%
2011-12-31HK$0.13 B-6.71%
2010-12-31HK$0.14 B11.63%
2009-12-31HK$0.12 B
2000-12-31HK$3.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
HK$277.27 B 5,602.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$476.92 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$70.75 B 1,355.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$42.54 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
HK$40.07 M-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$20.54 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$133.98 B 2,655.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$70.15 B 1,342.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
HK$5.01 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA